Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73

United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$75.77K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$522.95K

$95.67K on a plan · $0.00 straight out of an exercise

Sold at will

$427.28K

7 of 12 sales

Net

−$447.18K

−$351.51K against sales at will